A publicly traded (BWAY) medical device company that designs, manufactures, and sells a proprietary non-invasive neurostimulation system for the treatment of mental health disorders, which may not always respond to medication, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), among others. The patented form of neurostimulation is called Deep Transcranial Magnetic Stimulation (dTMS). The dTMS technology is backed by several multicenter double-blinded randomized controlled trials, demonstrating the technology's safety and efficacy. Currently, MDD and OCD treatments have been cleared by the FDA, and there are another 60 clinical trials worldwide underway that are addressing a variety of neuro-psychiatric conditions.

Drake Partners is a Management and Investment firm comprised of Healthcare Product and Service executives with extensive operating experience in successfully transitioning medical device companies from product concept through commercialization and exit. Our vast expertise includes market analysis, fund-raising, regulatory approvals, rapid prototypes, product development and manufacturing, product launch and commercial distribution. We also have relationships with professionals who offer legal support in formation and counsel for accounting and tax matters.

St. Jude purchased NeuroTherm in August 2014. St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and chronic pain management.

A leading medical device company focused on developing and delivering less invasive treatments for chronic pain. The company offers innovative solutions including radiofrequency ablation systems, intradiscal therapies, and vertebral compression fracture treatments in more than 65 countries.

A leading medical device company focused on developing and delivering less invasive treatments for chronic pain. The company offers innovative solutions including radiofrequency ablation systems, intradiscal therapies, and vertebral compression fracture treatments in more than 65 countries.

A leading medical device company focused on developing and delivering less invasive treatments for chronic pain. The company offers innovative solutions including radiofrequency ablation systems, intradiscal therapies, and vertebral compression fracture treatments in more than 65 countries.

Smith & Nephew is a diversified advanced medical technology business that supports healthcare professionals to improve the quality of life for their patients. The company holds leadership positions in Orthopedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma.

Stryker Biotech developed and marketed growth factors, namely recombinant human bone morphogenetic protein - 7 (rhBMP-7 or OP-1). Stryker is one of the world's leading medical technology companies. The company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine.